AlloVir, Inc. - stock earnings
ALVR Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -59.7 million USD | ? USD |
2023Q3 | -44.3 million USD | ? USD |
2023Q2 | -45.3 million USD | ? USD |
2023Q1 | -39.1 million USD | ? USD |
2022Q4 | -38.1 million USD | ? USD |
2022Q3 | -41.2 million USD | ? USD |
2022Q2 | -44.6 million USD | ? USD |
2022Q1 | -44.5 million USD | ? USD |
2021Q4 | -57.9 million USD | ? USD |
2021Q3 | -45.5 million USD | ? USD |
2021Q2 | -37.6 million USD | ? USD |
2021Q1 | -30.9 million USD | ? USD |
2020Q4 | -25.2 million USD | ? USD |
2020Q3 | -23.6 million USD | ? USD |
2020Q2 | -11.6 million USD | ? USD |
2020Q1 | -9.3 million USD | ? USD |
2019Q4 | -8.7 million USD | ? USD |
2019Q3 | -7.3 million USD | ? USD |
2019Q2 | -5.3 million USD | ? USD |
2019Q1 | -2.5 million USD | 165000 USD |
ALVR Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -190.4 million USD | ? USD |
2022 | -168.7 million USD | ? USD |
2021 | -172.0 million USD | ? USD |
2020 | -68.4 million USD | ? USD |
2019 | -21.8 million USD | 165000 USD |
2018 | -2.4 million USD | 1.1 million USD |
ALVR
Price: $0.80
52 week price:
Earnings Per Share: -1.83 USD
P/E Ratio: -0.43
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 86807
Market Capitalization: 85.8 million